BioSpace News Archive

Pharvaris (Nasdaq: PHVS), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies, including novel, small molecule bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, today announced the presentation of clinical data supporting the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of PHA121

The Index is designed to provide a measure of the performance of North American publicly listed life sciences companies focused on psychedelic medicines, and other companies with business activities in the psychedelics industry.

Visitors to the website will find a rebranded, upgraded online experience that includes a video section that will focus on business developments and commercialization topics. A variety of new content will be added on a regular basis.

The North America digital health market is set to record notable revenue gains in coming years owing to a steadily growing geriatric population, rising prevalence of different chronic disorders, and increasing healthcare costs in the region.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced the closing of its previously announced underwritten public offering of 46,875,000 shares of its common stock at a price to the public of $1.60 per share.

Willow Biosciences Inc. (“Willow” or the “Company”) (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the “Common Shares”) of the Company at a price of $1.65 per Common Share

The North America healthcare information technology market held a valuation of more than 69 billion in 2019 and is projected to surge at a fruitful CAGR of 14.1% between 2020 and 2026.

Ear, nose and throat diagnostic devices market has made some remarkable advances in recent decades.

The growth of the global neurovascular thrombectomy devices market is likely to be driven by the rising incidence of ischemic stroke, which is one of the leading types of stroke.

The big data in healthcare market is believed to be the future and game-changer of the healthcare sector with high adoption amongst medical professionals, government bodies, and even patients.